Powell Andrew Kenneth William - Net Worth and Insider Trading

Powell Andrew Kenneth William Net Worth

The estimated net worth of Powell Andrew Kenneth William is at least $2 Million dollars as of 2024-11-13. Powell Andrew Kenneth William is the SVP, General Counsel & Crp Sec of Medivation Inc and owns about 28,517 shares of Medivation Inc (MDVN) stock worth over $2 Million. Powell Andrew Kenneth William is the Director of Lifecore Biomedical Inc and owns about 1,000 shares of Lifecore Biomedical Inc (LFCR) stock worth over $7,155. Powell Andrew Kenneth William is also the Director of Aclaris Therapeutics Inc and owns about 500 shares of Aclaris Therapeutics Inc (ACRS) stock worth over $1,240. Details can be seen in Powell Andrew Kenneth William's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Powell Andrew Kenneth William has not made any transactions after 2019-01-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Powell Andrew Kenneth William

To

Powell Andrew Kenneth William Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Powell Andrew Kenneth William owns 6 companies in total, including Lifecore Biomedical Inc (LFCR) , Aclaris Therapeutics Inc (ACRS) , and Synthorx Inc (THOR) among others .

Click here to see the complete history of Powell Andrew Kenneth William’s form 4 insider trades.

Insider Ownership Summary of Powell Andrew Kenneth William

Ticker Comapny Transaction Date Type of Owner
LFCR Lifecore Biomedical Inc 2019-01-11 director
ACRS Aclaris Therapeutics Inc 2018-05-16 director
THOR Synthorx Inc 2020-01-23 director
LIMIT LIMIT 2016-09-28 SVP & General Counsel & Crp Sec
LIMIT LIMIT 2020-12-03 director
LIMIT LIMIT 2020-12-03 director

Powell Andrew Kenneth William Latest Holdings Summary

Powell Andrew Kenneth William currently owns a total of 3 stocks. Among these stocks, Powell Andrew Kenneth William owns 28,517 shares of Medivation Inc (MDVN) as of June 6, 2016, with a value of $2 Million and a weighting of 99.64%. Powell Andrew Kenneth William owns 1,000 shares of Lifecore Biomedical Inc (LFCR) as of January 11, 2019, with a value of $7,155 and a weighting of 0.31%. Powell Andrew Kenneth William also owns 500 shares of Aclaris Therapeutics Inc (ACRS) as of May 16, 2018, with a value of $1,240 and a weighting of 0.05%.

Latest Holdings of Powell Andrew Kenneth William

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MDVN Medivation Inc 2016-06-06 28,517 81.44 2,322,424
LFCR Lifecore Biomedical Inc 2019-01-11 1,000 7.16 7,155
ACRS Aclaris Therapeutics Inc 2018-05-16 500 2.48 1,240

Holding Weightings of Powell Andrew Kenneth William


Powell Andrew Kenneth William Form 4 Trading Tracker

According to the SEC Form 4 filings, Powell Andrew Kenneth William has made a total of 0 transactions in Medivation Inc (MDVN) over the past 5 years. The most-recent trade in Medivation Inc is the sale of 2,578 shares on June 6, 2016, which brought Powell Andrew Kenneth William around $155,763.

According to the SEC Form 4 filings, Powell Andrew Kenneth William has made a total of 0 transactions in Lifecore Biomedical Inc (LFCR) over the past 5 years. The most-recent trade in Lifecore Biomedical Inc is the acquisition of 525 shares on January 11, 2019, which cost Powell Andrew Kenneth William around $6,101.

According to the SEC Form 4 filings, Powell Andrew Kenneth William has made a total of 0 transactions in Aclaris Therapeutics Inc (ACRS) over the past 5 years. The most-recent trade in Aclaris Therapeutics Inc is the acquisition of 500 shares on May 16, 2018, which cost Powell Andrew Kenneth William around $9,560.

Insider Trading History of Powell Andrew Kenneth William

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Powell Andrew Kenneth William Trading Performance

GuruFocus tracks the stock performance after each of Powell Andrew Kenneth William's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Powell Andrew Kenneth William is -14.87%. GuruFocus also compares Powell Andrew Kenneth William's trading performance to market benchmark return within the same time period. The performance of stocks bought by Powell Andrew Kenneth William within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Powell Andrew Kenneth William's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Powell Andrew Kenneth William

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 4.42 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 1.18 LIMIT LIMIT LIMIT LIMIT LIMIT

Powell Andrew Kenneth William Ownership Network

Ownership Network List of Powell Andrew Kenneth William

No Data

Ownership Network Relation of Powell Andrew Kenneth William

Insider Network Chart

Powell Andrew Kenneth William Owned Company Details

What does Lifecore Biomedical Inc do?

Who are the key executives at Lifecore Biomedical Inc?

Powell Andrew Kenneth William is the director of Lifecore Biomedical Inc. Other key executives at Lifecore Biomedical Inc include 10 percent owner Wynnefield Partners Small Cap Value Lp I , Chief Financial Officer John D Morberg , and Executive Vice President James G Hall .

Lifecore Biomedical Inc (LFCR) Insider Trades Summary

Over the past 18 months, Powell Andrew Kenneth William made no insider transaction in Lifecore Biomedical Inc (LFCR). Other recent insider transactions involving Lifecore Biomedical Inc (LFCR) include a net purchase of 1,463,414 shares made by Christopher S Kiper , and a net purchase of 292,683 shares made by Wynnefield Partners Small Cap Value Lp I .

In summary, during the past 3 months, insiders sold 0 shares of Lifecore Biomedical Inc (LFCR) in total and bought 1,756,097 shares, with a net purchase of 1,756,097 shares. During the past 18 months, 0 shares of Lifecore Biomedical Inc (LFCR) were sold and 1,756,097 shares were bought by its insiders, resulting in a net purchase of 1,756,097 shares.

Lifecore Biomedical Inc (LFCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Lifecore Biomedical Inc Insider Transactions

No Available Data

Powell Andrew Kenneth William Mailing Address

Above is the net worth, insider trading, and ownership report for Powell Andrew Kenneth William. You might contact Powell Andrew Kenneth William via mailing address: C/o Collagenex Pharmaceuticals, Inc., 41 University Drive, Newtown Pa 18940.